- Product Code: SARS-012
- Synonyms/Product Alternate Names: Novel Coronavirus 2019-nCoV Spike Glycoprotein-S2, Recombinant
Please allow 2-3 weeks average availability
A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV or COVID-19 was found in the city of Wuhan, Hubei province of China on December 2019.
The 2019-nCoV (SARS-CoV-2) shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity, thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans.
RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.
The HEK293 derived recombinant protein contains the Novel Coronavirus 2019-nCoV Spike Glycoprotein S1, Wuhan-Hu-1 strain, amino acids 685-1211 fused to Fc tag at C-terminal.
Purification Method: Purified by Protein-G chromatographic technique.
Physical Appearance: Sterile Filtered clear solution.
Formulation: nCoV-S2 protein solution is supplied in DPBS.
Stability: Protein is shipped on ice packs. Upon arrival, Store at -20°C.
- Origin: HEK293
- Storage Conditions: -20 ℃
- Purity: > 85% pure as determined SDS-PAGE
Delivery Details: All quantities are subject to availability. Please allow 7-10 days for delivery.